Roy F. Chemaly, MD, MPH, FIDSA, FACP / Genovefa Papanicolaou, MD, FIDSA, Fellow ASCT - Cracking Down on Post-Transplant CMV: Guidance on Sequential Treatment With Newer Antiviral Agents

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME/NCPD information, and to apply for credit,
please visit us at PeerView.com/WAV865. CME/NCPD credit will be
available until March 25, 2025.


Cracking Down on Post-Transplant CMV: Guidance on Sequential
Treatment With Newer Antiviral Agents


The Medical College of Wisconsin is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians.


This activity was developed in collaboration with our educational
partner, PVI, PeerView Institute for Medical Education.


In support of improving patient care, PVI, PeerView Institute for
Medical Education, is jointly accredited by the Accreditation
Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.


SupportThis activity is supported by an
educational grant from Takeda Pharmaceuticals U.S.A., Inc.


Disclosure information is available at the beginning of the video
presentation.